Does IMIPENEM Cause Hepatic cytolysis? 42 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Hepatic cytolysis have been filed in association with IMIPENEM. This represents 2.2% of all adverse event reports for IMIPENEM.
42
Reports of Hepatic cytolysis with IMIPENEM
2.2%
of all IMIPENEM reports
0
Deaths
1
Hospitalizations
How Dangerous Is Hepatic cytolysis From IMIPENEM?
Of the 42 reports, 1 (2.4%) required hospitalization.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMIPENEM. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does IMIPENEM Cause?
Drug ineffective (351)
Off label use (202)
Condition aggravated (138)
Vomiting (137)
Drug resistance (117)
Nausea (111)
Dyspnoea (97)
Diarrhoea (90)
Pyrexia (90)
Product use in unapproved indication (85)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which IMIPENEM Alternatives Have Lower Hepatic cytolysis Risk?
IMIPENEM vs IMIPRAMINE
IMIPENEM vs IMIQUIMOD
IMIPENEM vs IMITREX
IMIPENEM vs IMMUNE GLOBULIN NOS
IMIPENEM vs IMPLANON